Other factors (PPARGC1, AGT) and drugs (losartan) related to vasoconstriction (Lu et al., 2016; Oberkofler et al., 2003) suggest that alterations in blood pressure, such as those seen in hypertension, might underlie CSD effects on bECs. The gene discussed is AGT; the disease is hypertensive disorder.